Skip to content
Opiant_logo Opiant Pharmaceuticals
Main Menu
  • Newsletter
  • Contact
  • Careers
  • Twitter
  • LinkedIn
  • About
    • Our Mission
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Therapy Areas
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Acute Cannabinoid Overdose
    • Patients & Families
    • Expanded Access Policy
    • Scientific Publications
  • Products & Pipeline
    • Pipeline Chart
  • Media Resources
    • News Releases
    • Resources
    • Perspectives
    • In the news
    • Community
    • Leadership
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events & Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financial & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements

Medical Advisory Board

David Nutt Read Bio
David Nutt DM, FRCP, FRCPsych, FMedSci, DLaws
Hannu Alho, MD Read Bio
Hannu Alho, MD
Sandra Comer, PhD headshot Read Bio
Sandra Comer, PhD
Read Bio
Richard C. Dart, MD, PhD
Thomas R. Kosten, MD Read Bio
Thomas R. Kosten, MD
Stephanie O’Malley, PhD Read Bio
Stephanie O’Malley, PhD
Marc Potenza Read Bio
Marc Potenza, MD, PhD
Sharon Walsh Read Bio
Sharon Walsh, PhD
Wim van den Brink, MD, PhD Read Bio
Wim van den Brink, MD, PhD
  • Twitter
  • LinkedIn
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Site Map
© Opiant Pharmaceuticals, 2023. All Rights Reserved.